InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding InflaRx N.V. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 25 | 1 | 37 | +13 |
| Shares | 3.61M | 10.0K | 18.5M | +14.9M (+414.6%) |
| Value | $7.08M | $11.5K | $82.7M | +$75.7M (+1,071.1%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held InflaRx N.V. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 2,900,000 | $12.9M | 1.90% |
| 683 Capital Management, LLC | 2,000,000 | $8.92M | 0.87% |
| Eversept Partners, LP | 1,915,113 | $8.54M | 0.90% |
| Point72 Asset Management, L.P. | 1,912,758 | $8.53M | 0.03% |
| Woodline Partners LP | 492,596 | $2.20M | 0.03% |
| Millennium Management LLC | 371,111 | $1.66M | 0.00% |
| Schonfeld Strategic Advisors LLC | 368,993 | $1.65M | 0.01% |
| J. Goldman & Co LP | 312,142 | $1.39M | 0.08% |
| UBS Oconnor LLC | 305,000 | $1.36M | 0.03% |
| Affinity Asset Advisors, LLC | 240,200 | $1.07M | 0.42% |
| Velan Capital Investment Management LP | 200,000 | $892.0K | 0.84% |
| Prelude Capital Management, LLC | 45,241 | $201.8K | 0.02% |
| Alps Advisors Inc | 39,778 | $177.4K | 0.00% |
| Jane Street Group, LLC | 34,891 | $155.6K | 0.00% |
| Jump Financial, LLC | 22,900 | $102.1K | 0.00% |
| BNP Paribas Arbitrage, SA | 21,296 | $95.0K | 0.00% |
| Mercer Global Advisors Inc | 10,000 | $45.0K | 0.00% |
Sold out (4)
Institutions that held InflaRx N.V. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| IPG Investment Advisors LLC | 25,900 | $50.2K |
| Acadian Asset Management LLC | 19,404 | $37.0K |
| Group One Trading, L.P. | 7,353 | $14.3K |
| Citadel Advisors LLC | 412 | $799 |
Not filed for Q2 2023 yet (1)
Institutions that held InflaRx N.V. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Andesa Financial Management Inc. | 10,000 | $11.5K |